Asuragen, Inc. To Present Innovations In Fragile X Testing At Upcoming American College Of Medical Genetics And Genomics (ACMG) Annual Clinical Genetics Meeting

AUSTIN, Texas--(BUSINESS WIRE)--Asuragen, Inc., a leading molecular diagnostics company and innovator in fragile X testing capabilities, will present at the upcoming American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, March 24-28, 2015 in Salt Lake City, UT. The company will showcase its broad expertise in fragile X-related diagnostic products and development efforts in the areas of oncology, genetic testing and next-generation sequencing (NGS).

Help employers find you! Check out all the jobs and post your resume.